Navigation Links
Medivir: R&D Day
Date:11/18/2010

TMC435, a once daily hepatitis C protease inhibitor in phase 2b development, which is jointly developed by Medivir and Tibotec Pharmaceuticals, and present an update on the product and R&D pipeline.

In order to access the event remotely, a live audio webcast will be streamed from the R&D session. To access the webcast please visit the Company's website http://www.medivir.se.

In a separate press release issued today Medivir announced positive phase 2b TMC435 data from the ASPIRE (C206) study. These results will be discussed during the R&D session via a conference call at 15:00 (GMT)/ 16:00 (CET)/10:00 (EST).

To participate in the conference call at 15:00 (GMT) which will discuss the phase 2b TMC435 ASPIRE (C206) data announced today please dial: UK: +44- (0)20-7906-8535, Sweden Access Number: +46(0)85-063-9549 or US Access Number: +1-703-865-2821. A seven day replay of the conference call can be accessed via: UK: +44(0)20-3364-5943, Sweden: +46(0)20-089-6353, US: +1- 866-286-6997, please quote the passcode 281259#.

About Medivir

Medivir is an emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseases. Medivir has world class expertise in polymerase and protease drug targets and drug development. Medivir has a strong R&D portfolio and has recently launched its first product Xerese(TM)/Xerclear(R). Medivir's key pipeline asset, TMC435, a protease inhibitor, is in phase 2b clinical development for Hepatitis C and is partnered with Tibotec Pharmaceuticals.

Xerese(TM)/Xerclear(R) is an innovative treatment for cold sores, which has been approved in both the US and Europe. It is partnered with GSK to be sold OTC in Europe and Russia and with Meda in North America. Medivir has retained the Rx rights for Xerclear(R) in Sweden and Finland.

For more information about Medivir, please visit the Comp
'/>"/>

SOURCE Medivir
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany
2. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-2025
3. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
4. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
5. RIKEN Center for Genomics Medicine Chooses Genedata Expressionist for High Throughput Proteomics R&D
6. US Nanotechnology Instrument Manufacturer Proves the Success of R&D Stimulus
7. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
8. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
9. Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery
10. UMass Boston Opens Venture Development Center to Expand R&D Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
(Date:2/26/2015)... TORONTO , Feb. 26, 2015 /PRNewswire/ - SQI ... SQIDF), a life sciences company that develops and commercializes ... reported its financial and operational results for the fiscal ... this press release are in Canadian dollars (CAD), unless ... Company continued to win new business from our existing ...
(Date:2/26/2015)... LAUDERDALE, Fla. , Feb. 26, 2015 ... discussed growth priorities driven by key research advancements and ... segments at today,s Bank of America Merrill Lynch 2015 ... met the challenge of building grain supplies the last ... to continue at the pace of the last decade, ...
(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015 The ... navigate this ever-changing arena, Frost & Sullivan will host its ... & Sullivan Executive MindXchange , March 8 to 10, at ... San Diego, Calif. This event is ... connected healthcare leaders to discuss industry disruptions and how to ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3
... Colo. , May 11 N30 Pharma (N30), a biopharmaceutical company focused ... endogenous, bioactive nitric oxide, announced today that it has completed a $10 million ... , , ... Deerfield Management. , , , ...
... SAN DIEGO , May 11 ... Biomatrica Connect™, a solution-centric partnership program established with ... room temperature storage and management of nucleic acids. ... scientific/industry partnership for the development, testing, validation and ...
... at the University of Gothenburg, Sweden, have managed, with the ... of atoms during photosynthesis an achievement that has been ... European Synchrotron Radiation Facility in Grenoble is home to one ... beams are used by researchers to photograph and study life,s ...
Cached Biology Technology:Biomatrica Launches New Partnership Program - Biomatrica Connect(TM) 2Biomatrica Launches New Partnership Program - Biomatrica Connect(TM) 3Biomatrica Launches New Partnership Program - Biomatrica Connect(TM) 4Biomatrica Launches New Partnership Program - Biomatrica Connect(TM) 5Biomatrica Launches New Partnership Program - Biomatrica Connect(TM) 6
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... corporate website ( http://www.nxt-id.com/ ) as part of its ... wallet. The Company launched its new consumer website for ... Pereira , CEO of NXT-ID said, "Our new corporate ...
(Date:2/5/2015)... , Jan. 28, 2015 Research and ... the addition of the "Global Biometrics Market ... Regions and Countries " report to their offering. ... Asia-Pacific is anticipated to ... 2015, owing to increasing government spending towards IT ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... the prism of our senses, the human brain has ways ... is seen, for example, in the placebo effect, when simple ... seen to ease pain or have some other beneficial physiological ... the body to respond is largely a mystery of neuroscience. ...
... of Japanese scientists has discovered that cannabinoids can cause some ... the sites of infection and inflammation. These findings, which ... Biological Chemistry, could have potential use in the development of ... chemicals that include marijuana. These compounds bind to and ...
... are potentially limitless. In the long term it will ... to combat neurological disorders. What's more, it could allow ... as their CPU. , Those applications are potentially decades ... technology could enable very advanced and sophisticated drug screening ...
Cached Biology News:Great (taste) expectations: Study shows brain anticipates taste, shifts gears 2Researchers get neurons and silicon talking 2
... chamber assembly (1 each) Components (chamber ... user guide plastic tweezersChambers are stainless ... and reused. The chamber is designed for ... and all custom oligo microarrays, in conjunction ...
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
... Staining Kit is a very sensitive immunohistochemical ... cells, containing both anti-von Willebrand Factor and ... a variety of species. This AP kit ... staining of frozen and paraffin-embedded sections in ...
... For separation and ... Efficient separation of nuclei from ... in sample complexity, greatly facilitating ... Subfractionation of nucleic acid binding ...
Biology Products: